• Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. (wikipedia.org)
  • Dijkshoorn L , Aucken H , Gerner-Smidt P , Janssen P , Kaufmann ME , Garaizar J , Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. (cdc.gov)
  • Nemec A , Krizova L , Maixnerova M , Tanny der Reijden JK , Deschaght P , Passet V , Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. (cdc.gov)
  • Dijkshoorn L , Van Harsselaar B , Tjernberg I , Bouvet PJ , Vaneechoutte M . Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species. (cdc.gov)
  • van den Broek PJ , van der Reijden TJ , van Strijen E , Helmig-Schurter AV , Bernards AT , Dijkshoorn L . Endemic and epidemic acinetobacter species in a university hospital: an 8-year survey. (cdc.gov)
  • Acinetobacter nosocomialis is a gram-negative, strictly aerobic bacterium from the genus Acinetobacter isolated from a patient at MetroHealth in Cleveland, Ohio. (wikipedia.org)
  • Imipenem-resistant Acinetobacter genomic species 13TU isolates produced VIM-2 metallo-beta-lactamase, while imipenem-resistant A. baumannii isolates produced OXA-23 and/or OXA-51 beta-lactamase. (nih.gov)
  • The internal laboratory records of the microbiology department of the Giessen Veterinary Faculty (Institute for Hygiene and Infectious Diseases of Animals, Giessen, Germany) noted an increase in antimicrobial drug-resistant Acinetobacter isolates. (cdc.gov)
  • To assess the species and type diversity of these organisms, we investigated a set of isolates from Giessen and other veterinary clinics obtained during a 9-year period by a combination of genotypic methods and compared the isolates for their susceptibility to antimicrobial drugs. (cdc.gov)
  • Fifty-two isolates were identified as belonging to A. baumannii and 3 to A. pittii ( Acinetobacter gen. sp. (cdc.gov)
  • For species identification, isolates were compared with reference strains of all described Acinetobacter species included in the Leiden University Medical Center AFLP database (Leiden, the Netherlands). (cdc.gov)
  • Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. (wikipedia.org)
  • Nemec A , Krizova L , Maixnerova M , Tanny der Reijden JK , Deschaght P , Passet V , Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. (cdc.gov)
  • To investigate the differences in antimicrobial susceptibility and resistance mechanisms against imipenem between Acinetobacter baumannii and Acinetobacter genomic species 13TU. (nih.gov)
  • The resistance rates of A. baumannii to most antimicrobial agents were higher than those of other Acinetobacter species, while the resistance rate to imipenem was the highest in Acinetobacter genomic species 13TU. (nih.gov)
  • Acinetobacter nosocomialis is a gram-negative, strictly aerobic bacterium from the genus Acinetobacter isolated from a patient at MetroHealth in Cleveland, Ohio. (wikipedia.org)
  • In 1911, a Dutch microbiologist by the name of Martinus Willem Beigerinck discovered an aerobic, gram-negative, non-fermentative bacterium we now know to be of the genus Acinetobacter. (medscape.com)
  • Within the genus Acinetobacter, A. baumannii is clinically the most relevant species, frequently involved in hospital outbreaks and affecting critically ill humans ( 1 , 2 ). (cdc.gov)
  • Dijkshoorn L , Aucken H , Gerner-Smidt P , Janssen P , Kaufmann ME , Garaizar J , Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. (cdc.gov)
  • van den Broek PJ , Arends J , Bernards AT , De Brauwer E , Mascini EM , van der Reijden TJ , Epidemiology of multiple Acinetobacter outbreaks in the Netherlands during the period 1999-2001. (cdc.gov)
  • Amplified fragment length polymorphism (AFLP) DNA fingerprint analysis was performed as described for confirmative species identification, for strain typing, and for clone identification ( 4 , 12 , 13 ). (cdc.gov)
  • A total of 232 non-duplicate Acinetobacter species were consecutively collected from two Korean hospitals in Daegu, Republic of Korea, between November 2004 and November 2005. (nih.gov)
  • Acinetobacter baumannii is no longer isolated only rarely in hospitals, and the cause of this increase in detection is not clear. (medscape.com)
  • These are the 3 species of the most clinical importance, causing a vast majority of Acinetobacter infections, but they cannot be differentiated by routine diagnostic tests. (medscape.com)
  • For precise species identification, amplified ribosomal DNA restriction analysis was performed. (cdc.gov)
  • The role of Acinetobacter baumannii as a nosocomial pathogen for dogs and cats in an intensive care unit. (cdc.gov)
  • Acinetobacter baumannii also has the ability to form biofilms, which may play a role in the process of colonization. (medscape.com)
  • The role of acinetobacters in diseases of hospitalized animals is largely unknown. (cdc.gov)
  • Acinetobacter baumannii has emerged as a significant hospital pathogen, quickly becoming resistant to commonly prescribed antimicrobials. (medscape.com)
  • [ 1 ] Acinetobacter began to be recognized as a significant hospital pathogen in the late 1970s, but at that time it was easily treated as it was susceptible to commonly used antimicrobials. (medscape.com)